Skip to main content
SpringerLink
Log in

Selective Sentinel Lymph Node Mapping and Dissection for Malignant Melanoma

  • Chapter
Atlas of Selective Sentinel Lymphadenectomy for Melanoma, Breast Cancer and Colon Cancer

Part of the book series: Cancer Treatment and Research ((CTAR,volume 111))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Albertini JJ, Cruse CW, Rapaport D, et al. Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma. Annals of Surgery 1996;223(2):217–24

    Article  PubMed  CAS  Google Scholar 

  • Alex JC, Krag DN. Gamma-probe-guided localization of lymph nodes. Surgical Oncology 1993;2(3):137–44

    Article  PubMed  CAS  Google Scholar 

  • Balch CM, Soong S, Ross MI, et al. Long-termresults of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0mm). Annals of Surgical Oncology 2000;7(2):87–97

    Article  PubMed  CAS  Google Scholar 

  • Balch CM, Soong S, Bartolucci A, et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Annals of Surgery 1996;224(3):255–66

    Article  PubMed  CAS  Google Scholar 

  • Balch CM. The role of elective lymph node dissection in melanoma: rationale, results and controversies. Journal of Clinical Oncology 1988;6(1):163–72

    PubMed  CAS  Google Scholar 

  • Balch CM, Soong SJ, Murad TN, et al. A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II). Annals of Surgery 1981;193(3):377–88

    PubMed  CAS  Google Scholar 

  • Berman CG, Norman J, Cruse CW, et al. Lymphoscintigraphy in malignant melanoma. Annals of Plastic Surgery 1992;28(l):29–32

    PubMed  CAS  Google Scholar 

  • Bonenkamp JJ, Logan DR, Suemnig AA, Thompson JF. The cost of sentinel node biopsy (SNB) for melanoma. [Abstract] Melanoma Research 2001; 11 (Supplement 1):S107

    Google Scholar 

  • Bostick P, Essner R, Sarantou T, et al. Intraoperative lymphatic mapping for early-stage melanoma of the head and neck. American Journal of Surgery 1997;174(5):536–539

    Article  PubMed  CAS  Google Scholar 

  • Callery C, Cochran AJ, Roen DJ, et al. Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph nodes. Annals of Surgery 1982;196(1):69–75

    PubMed  CAS  Google Scholar 

  • Cohen MH, Ketcham AS, Felix EL. Prognostic factors in patients undergoing lymphadenectomy for malignant melanoma. Annals of Surgery 1977;186(5):635–42

    PubMed  CAS  Google Scholar 

  • Coit D, Wallack M, Balch C. Society of Surgical Oncology practice guidelines. Melanoma surgical practice guidelines. Oncology 1997;11(9):1317–23

    PubMed  CAS  Google Scholar 

  • Coldiron B. No evidence to support delay in excision of malignant melanoma. [Letter] Archives of Dermatology 2000;136(10):1269–70

    Article  PubMed  CAS  Google Scholar 

  • Das Gupta TK. Results of treatment of 269 patients with primary cutaneous melanoma: a five-year prospective study. Annals of Surgery 1977;186:201–9

    PubMed  CAS  Google Scholar 

  • Emilia JCD, Lawrence W. Sentinel lymph node biopsy in malignant melanoma: The standard of care? Journal of Surgical Oncology 1997;65(3):153–4

    PubMed  CAS  Google Scholar 

  • Eshima D, Fauconnier T, Eshima L, et al. Radiopharmaceuticals for Lymphoscintigraphy: Including Dosimetry and Radiation Considerations. Seminars in Nuclear Medicine 2000;30(1):25–32

    PubMed  CAS  Google Scholar 

  • Fee HJ, Robinson DS, Sample WF, et al. The determination of lymph shed by colloidal gold scanning patients with malignant melanoma: a preliminary study. Surgery 1978;84(5):626–32

    PubMed  CAS  Google Scholar 

  • Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. Journal of Clinical Oncology 1999;17(3):976–83

    PubMed  CAS  Google Scholar 

  • Glass LF, Messina JL, Cruse W, et al: The use of intraoperative radiolymphoscintigraphy for sentinel node biopsy in patients with malignant melanoma. Dermatologic Surgery 1996;22(8):715–20

    PubMed  CAS  Google Scholar 

  • Glass FL, Fenske NA, Messina JL, et al. The role of selective lymphadenectomy in the management of patients with malignant melanoma. Dermatologic Surgery 1995;21(11):979–83

    PubMed  CAS  Google Scholar 

  • Houghton A, Coit D, Bloomer W, et al. NCCN melanoma practice guidelines. National Comprehensive Cancer Network. Oncology 1998;12(7a):153–77

    PubMed  CAS  Google Scholar 

  • Joseph E, Messina J, Glass FL, et al. Radioguided surgery for the ultrastaging of the patient with melanoma. Cancer Journal 1997;3(6):341–5

    PubMed  CAS  Google Scholar 

  • Kapteijn BA, Nieweg OE, Liem I, et al. Localizing the sentinel node in cutaneous melanoma: gamma probe detection versus blue dye. Annals of Surgical Oncology 1997;4(2):156–60

    PubMed  CAS  Google Scholar 

  • Karakousis CP. Surgical Treatment of Malignant Melanoma. In: Leong SPL, editor. Surgical Clinics of North America: Cutaneous Malignant Melanoma. Philadelphia: WB Saunders, 1996a;76(6):1299–312

    Google Scholar 

  • Karakousis CP, Velez AF, Spellman JE, Jr., et al. The technique of sentinel node biopsy. European Journal of Surgical Oncology 1996b;22(3):271–5

    CAS  Google Scholar 

  • Kirkwood JM, Strawderman MH, Ernstoff MS. Interferon alpha-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. Journal of Clinical Oncology 1996;14(1):7–17

    PubMed  CAS  Google Scholar 

  • Kowalsky RJ, Perry JR. Radiopharmaceuticals in Nuclear Medicine Practice. Los Altos: Appleton and Lange; 1987.

    Google Scholar 

  • Krag DN, Meijer SJ, Weaver DL, et al. Minimal-access surgery for staging of malignant melanoma. Archives of Surgery 1995;130(6):654–8

    PubMed  CAS  Google Scholar 

  • Krouse RS, Schwarz RE. Blue dye for sentinel lymph node mapping: not too sensitive, but too hypersensitive? [Letter]. Annals of Surgical Oncology. In press 2000.

    Google Scholar 

  • Lamki LM, Logic JR. Defining lymphatic drainage patterns with cutaneous lymphoscintigraphy. In: Balch CM, Hougton AN, Milton GW, et al, editors. Cutaneous Melanoma. 2nd ed. Philadelphia: J.B. Lippincott; 1992. p 367–75.

    Google Scholar 

  • Lane N, Lattes R, Malm J. Clinicopathological correlation in a series of 117 malignant melanomas of the skin of adults. Cancer 1958;11:1025–43

    PubMed  CAS  Google Scholar 

  • Leong SPL, Acthem T, Miller J, et al. Clinical Significance of Melanoma Micrometastasis to Sentinel Lymph Nodes and Other High Risk Factors. [Abstract] Proceedings of the American Society of Clinical Oncology; New Orleans, LA. 2000a.

    Google Scholar 

  • Leong SPL, Donegan E, Heffernon W, et al. Adverse reactions to isosulfan blue during selective sentinel lymph node dissection in melanoma. Annals of Surgical Oncology 2000b;7:361–366

    Article  PubMed  CAS  Google Scholar 

  • Leong SPL. Blue dye for sentinel lymph node mapping: not too sensitive, but too hypersensitive? [Letter, Reply] Annals of Surgical Oncology. In press 2000c.

    Google Scholar 

  • Leong SPL, Nguyen L, Morita E, et al. Superiority of Radiocolloid over Isosulfan Blue Dye in the Detection of Melanoma Sentinel Lymph Nodes. [Abstract] 2nd International Sentinel Node Congress; Santa Monica, CA. December, 2000d

    Google Scholar 

  • Leong SPL. No evidence to support delay in excision of malignant melanoma. [Letter, Reply] Archives of Dermatology 2000e;136(10):1269–70

    PubMed  Google Scholar 

  • Leong SPL, Habib FA, Achtem TA, et al. Discordancy between clinical predictions versus lymphoscintigraphic and intraoperative mapping of sentinel lymph node drainage of primary melanoma. Archives of Dermatology 1999a;135(12):1472–6

    Article  PubMed  CAS  Google Scholar 

  • Leong SPL, Steinmetz I, Habib FA, et al. Optimal selective sentinel lymph node dissection in primary malignant melanoma. Archives of Surgery 1997;132(6):666–73

    PubMed  CAS  Google Scholar 

  • Lingam MK, Mackie RM, McKay AJ. Intraoperative identification of sentinel lymph node in patients with malignant melanoma. British Journal of Cancer 1997;75(10):1505–8

    PubMed  CAS  Google Scholar 

  • McNeer G, Das Gupta TK. Prognosis in malignant melanoma. Surgery 1964;56:512–8

    Google Scholar 

  • Meyer CM, Lecklitner ML, Logic JR, et al. Technetium-99m sulfur-colloid cutaneous lymphoscintigraphy in the management of truncal melanoma. Radiology 1979;131(1):205–9

    PubMed  CAS  Google Scholar 

  • Morton DL, Chan AD. Current status of intraoperative lymphatic mapping and sentinel lymphadenectomy for melanoma: is it standard of care? Journal of the American College of Surgeons 1999;189(2):214–23

    Article  PubMed  CAS  Google Scholar 

  • Morton DL, Wen DR, Cochran AJ. Management of early stage melanoma by intraoperative lymphatic mapping and selective lymphadenectomy. In: Coit DG, editor. Surgical Oncology Clinics of North America: Lymph Node Dissection in Malignant Melanoma. Philadelphia: WB Saunders, 1992a;1(2):247–59

    Google Scholar 

  • Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Archives of Surgery 1992b;127(4):392–9

    PubMed  CAS  Google Scholar 

  • Pijpers R, Borgstein PJ, Meijer S, et al. Sentinel node biopsy in melanoma patients: dynamic lymphoscintigraphy followed by intraoperative gamma probe and vital dye guidance. World Journal of Surgery 1997;21(8):788–92, discussion 793

    Article  PubMed  CAS  Google Scholar 

  • Pijpers R, Collet GJ, Meijer S, et al. The impact of dynamic lymphoscintigraphy and gamma probe guidance on sentinel node biopsy in melanoma. European Journal of Nuclear Medicine 1995;22(11):1238–41

    Article  PubMed  CAS  Google Scholar 

  • Reintgen DS. Changing standards of surgical care for melanoma patients. Annals of Surgical Oncology 1996;3:327–8

    PubMed  CAS  Google Scholar 

  • Reintgen D, Albertini J, Berman, et al. Accurate nodal staging of malignant melanoma. Cancer Control Journal of Moffitt Cancer Center 1995;2:405–14

    Google Scholar 

  • Reintgen DS, Cruse CW, Wells K. The orderly progression of melanoma nodal metastases. Annals of Surgery 1994;220(6):759–67

    PubMed  CAS  Google Scholar 

  • Rivers JK, Roof MI. Sentinel lymph-node biopsy in melanoma: is less surgery better? Lancet 1997;350(9088):1336–7

    Article  PubMed  CAS  Google Scholar 

  • Robert M, Wen D, Cochran A. Pathological evaluation of the regional lymph nodes in malignant melanoma. Seminars in Diagnostic Pathology 1993;10(1):102–15

    PubMed  CAS  Google Scholar 

  • Roses DF, Provet JA, Harris MN, et al. Prognosis of patients with pathologic stage II cutaneous malignant melanoma. Annals of Surgery 1985;201(1):103–7

    PubMed  CAS  Google Scholar 

  • Ross MI, Reintgen DS, Balch C. Selective lymphadenectomy: Emerging role for lymphatic mapping and sentinel node biopsy in the management of early stage melanoma. Seminars in Surgical Oncology 1993;9(3):219–23

    PubMed  CAS  Google Scholar 

  • Sim FH, Taylor WF, Ivins JC, et al. A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma: preliminary results. Cancer 1978;41(3):948–56

    PubMed  CAS  Google Scholar 

  • Sullivan DC, Croker BP, Harris CC, et al. Lymphoscintigraphy in malignant melanoma: 99mTc antimony sulfur colloid. American Journal of Roentgenology 1981;137(4):847–51

    PubMed  CAS  Google Scholar 

  • Thompson JF, McCarthy WH, Bosch CM, et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Research 1995;5(4):255–60

    PubMed  CAS  Google Scholar 

  • Thompson J, McCarthy W, Robinson E. Sentinel lymph node biopsy in 102 patients with clinical stage I melanoma undergoing elective lymph node dissection, 47th Cancer symposium Society of Surgical Oncology. Houston, Texas, 1994.

    Google Scholar 

  • Uren DF, Howman-Giles RB, Shaw HM, et al. Lymphoscintigraphy in high risk melanoma of the trunk: Predicting draining node groups, defining lymphatic channels and locating the sentinel node. Journal of Nuclear Medicine 1993;34(9):1435–40

    PubMed  CAS  Google Scholar 

  • Van der Veen H, Hoekstra O, Paul M, et al. Gamma probe-guided sentinel node biopsy to select patients with melanoma for lymphadenectomy. British Journal of Surgery 1994;81(12):1769–70

    PubMed  Google Scholar 

  • Veronesi U, Adamus J, Bandiera DC. Inefficacy of immediate node dissection in stage I melanoma of the limbs. New England Journal of Medicine 1977;297(12):627–30

    Article  PubMed  CAS  Google Scholar 

  • Wanebo HJ, Harpole D, Teates CD. Radionuclide lymphoscintigraphy with technetium 99m antimony sulfide colloid to identify lymphatic drainage of cutaneous melanoma at abiguous sites in the head and neck and trunk. Cancer 1985;55(6):1403–13

    PubMed  CAS  Google Scholar 

  • Wang X, Heller R, VanVoorheis N, et al. Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma. Annals of Surgery 1994;220(6):768–74

    PubMed  CAS  Google Scholar 

  • Wells KE, Rapaport DP, Cruse CW, et al. Sentinel lymph node biopsy in melanoma of the head and neck. Plastic and Reconstructive Surgery 1997;100(3):591–4

    PubMed  CAS  Google Scholar 

  • White DC, Schuler FR, Pruitt SK, et al. Timing of sentinel lymph node mapping after lymphoscintigraphy. Surgery 1999;126(2):156–61

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Stanley P. L. Leong MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of California, San Francisco, USA

    Stanley P. L. Leong

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Kluwer Academic Publishers

About this chapter

Cite this chapter

Leong, S.P.L. (2002). Selective Sentinel Lymph Node Mapping and Dissection for Malignant Melanoma. In: Leong, S.P.L. (eds) Atlas of Selective Sentinel Lymphadenectomy for Melanoma, Breast Cancer and Colon Cancer. Cancer Treatment and Research, vol 111. Springer, Boston, MA. https://doi.org/10.1007/0-306-47822-6_3

Download citation

  • DOI: https://doi.org/10.1007/0-306-47822-6_3

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4020-7013-6

  • Online ISBN: 978-0-306-47822-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation